Skip to content
February 08, 2023

Equity.Guru

Investment information for the new generation

NexoBrid

MediWound (MDWD.Q), a biopharmaceutical company focused on developing solutions for tissue repair and regeneration, today announced positive topline results from its pivotal phase 3 pediatric clinical study (CIDS – Children…